Cite
HARVARD Citation
Robak, T. et al. (2013). Rozrolimupab, a mixture of recombinant human monoclonal anti‐D antibodies, for the treatment of primary immune thrombocytopenia – a review. ISBT science series. pp. 102-108. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Robak, T. et al. (2013). Rozrolimupab, a mixture of recombinant human monoclonal anti‐D antibodies, for the treatment of primary immune thrombocytopenia – a review. ISBT science series. pp. 102-108. [Online].